eTheRNA Immunotherapies NV - Company Review
eTheRNA Immunotherapies NV - Company ReviewSummary
eTheRNA Immunotherapies NV (eTheRNA) focuses on the development of novel immunotherapies for the treatment of cancers and infectious diseases. Its pipeline portfolio includes mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious diseases. It provides preclinical and clinical proof to support further development of the TriMix technology into an injectable in vivo product. eTheRNA seeks for collaborative partnerships with pharma companies that enables to develop and commercialize the differentiated TriMix-based immunotherapies. It also develops drugs for infectious diseases such as influenza, pneumonia, tuberculosis, Lyme disease, HIV/AIDS et cetera. The company is a spin-off of Vrije Universiteit Brussel. eTheRNA is headquartered in Antwerp, Belgium.
This comprehensive company report of eTheRNA Immunotherapies NV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.